Parkinsons disease Drug Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Recession Impact Analysis)
ID : MRU_
5043 | Date :
Jan, 2023 | Pages :
180 | Region : Global |
Publisher : 99 Strategy
Researchers are working to develop new and improved therapies for people with Parkinsons disease (PD). There have been many drugs that have been approved to treat Parkinson disease.
The Global Parkinsons disease Drug Market touched xxx million USD with a CAGR xx % from 2018-2022 around the world. In the future, it is predicted to reach xxx million USD in 2023 with a CAGR xx % from 2023-2030.
As the report focuses on global Parkinsons disease Drug Market, mainly in Europe and Asia Pacific, North America, Middle East and Africa, and South America. This report segmented the Market on the basis of regions, manufacturers, applications, and type.
in addition, this report introduces Market competition situation among the vendors and company profile, besides, Market price analysis and value chain features are covered in this report.
In Market segmentation by manufacturers, the report covers the following companies-
Teva
Novartis AG
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax Laboratories
Lundbeck
Sun Pharma
Wockhardt
UCB
Valeant Pharmaceuticals
Acadia
In Market segmentation by geographical regions, the report has analyzed the following regions- North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types covers:
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
In Market segmentation by applications :
Hospital
Online
Retail Pharmacies
Apart from the drivers, restraints, and opportunities, the report also offers competitive landscape, including various growth strategies adopted by profiled players for establishing significant position in the industry. The segmentation included in the comprehensive report will help respectable manufacturers to set up their processing units in the regions and increase their global presence. This would also benefit the industry and increase the company\'s product portfolio.
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Parkinsons disease Drug Market for the forecast period 2023-2030?
• What are the driving forces in the Parkinsons disease Drug Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Parkinsons disease Drug industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Parkinsons disease Drug Market Size Growth Rate by Type (2020-2030)
1.3.2 Carbidopa/Levodopa
1.3.3 Dopamine Receptor Agonists
1.3.4 MAO-Inhibitors
1.4 Market Segment by Application
1.4.1 Global Parkinsons disease Drug Market Share by Application (2020-2030)
1.4.2 Hospital
1.4.3 Online
1.4.4 Retail Pharmacies
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinsons disease Drug Market Size
2.1.1 Global Parkinsons disease Drug Revenue 2015-2030
2.1.2 Global Parkinsons disease Drug Sales 2015-2030
2.2 Parkinsons disease Drug Growth Rate by Regions
2.2.1 Global Parkinsons disease Drug Sales by Regions 2018 - 2022
2.2.2 Global Parkinsons disease Drug Revenue by Regions 2018 - 2022
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Parkinsons disease Drug Sales by Manufacturers
3.1.1 Parkinsons disease Drug Sales by Manufacturers 2018 - 2022
3.1.2 Parkinsons disease Drug Sales Market Share by Manufacturers 2018 - 2022
3.2 Revenue by Manufacturers
3.2.1 Parkinsons disease Drug Revenue by Manufacturers (2018 - 2022)
3.2.2 Parkinsons disease Drug Revenue Share by Manufacturers (2018 - 2022)
3.2.3 Global Parkinsons disease Drug Market Concentration Ratio (CR5 and HHI)
3.3 Parkinsons disease Drug Price by Manufacturers
3.4 Key Manufacturers Parkinsons disease Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Parkinsons disease Drug Market
3.6 Key Manufacturers Parkinsons disease Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Carbidopa/Levodopa Sales and Revenue (2018 - 2022)
4.1.2 Dopamine Receptor Agonists Sales and Revenue (2018 - 2022)
4.1.3 MAO-Inhibitors Sales and Revenue (2018 - 2022)
4.2 Global Parkinsons disease Drug Sales Market Share by Type
4.3 Global Parkinsons disease Drug Revenue Market Share by Type
4.4 Parkinsons disease Drug Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Parkinsons disease Drug Sales by Application
6 United States
6.1 United States Parkinsons disease Drug Breakdown Data by Company
6.2 United States Parkinsons disease Drug Breakdown Data by Type
6.3 United States Parkinsons disease Drug Breakdown Data by Application
7 European Union
7.1 European Union Parkinsons disease Drug Breakdown Data by Company
7.2 European Union Parkinsons disease Drug Breakdown Data by Type
7.3 European Union Parkinsons disease Drug Breakdown Data by Application
8 China
8.1 China Parkinsons disease Drug Breakdown Data by Company
8.2 China Parkinsons disease Drug Breakdown Data by Type
8.3 China Parkinsons disease Drug Breakdown Data by Application
9 Rest of World
9.1 Rest of World Parkinsons disease Drug Breakdown Data by Company
9.2 Rest of World Parkinsons disease Drug Breakdown Data by Type
9.3 Rest of World Parkinsons disease Drug Breakdown Data by Application
9.4 Rest of World Parkinsons disease Drug Breakdown Data by Countries
9.4.1 Rest of World Parkinsons disease Drug Sales by Countries
9.4.2 Rest of World Parkinsons disease Drug Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Teva
10.1.1 Teva Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Parkinsons disease Drug
10.1.4 Parkinsons disease Drug Product Introduction
10.1.5 Teva Recent Development
10.2 Novartis AG
10.2.1 Novartis AG Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Parkinsons disease Drug
10.2.4 Parkinsons disease Drug Product Introduction
10.2.5 Novartis AG Recent Development
10.3 GSK
10.3.1 GSK Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Parkinsons disease Drug
10.3.4 Parkinsons disease Drug Product Introduction
10.3.5 GSK Recent Development
10.4 AbbVie
10.4.1 AbbVie Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Parkinsons disease Drug
10.4.4 Parkinsons disease Drug Product Introduction
10.4.5 AbbVie Recent Development
10.5 Merck
10.5.1 Merck Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Parkinsons disease Drug
10.5.4 Parkinsons disease Drug Product Introduction
10.5.5 Merck Recent Development
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Parkinsons disease Drug
10.6.4 Parkinsons disease Drug Product Introduction
10.6.5 Boehringer Ingelheim Recent Development
10.7 Impax Laboratories
10.7.1 Impax Laboratories Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Parkinsons disease Drug
10.7.4 Parkinsons disease Drug Product Introduction
10.7.5 Impax Laboratories Recent Development
10.8 Lundbeck
10.8.1 Lundbeck Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Parkinsons disease Drug
10.8.4 Parkinsons disease Drug Product Introduction
10.8.5 Lundbeck Recent Development
10.9 Sun Pharma
10.9.1 Sun Pharma Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Parkinsons disease Drug
10.9.4 Parkinsons disease Drug Product Introduction
10.9.5 Sun Pharma Recent Development
10.10 Wockhardt
10.10.1 Wockhardt Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Parkinsons disease Drug
10.10.4 Parkinsons disease Drug Product Introduction
10.10.5 Wockhardt Recent Development
10.11 UCB
10.12 Valeant Pharmaceuticals
10.13 Acadia
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Parkinsons disease Drug Sales Channels
11.2.2 Parkinsons disease Drug Distributors
11.3 Parkinsons disease Drug Customers
12 Market Forecast
12.1 Global Parkinsons disease Drug Sales and Revenue Forecast 2020-2030
12.2 Global Parkinsons disease Drug Sales Forecast by Type
12.3 Global Parkinsons disease Drug Sales Forecast by Application
12.4 Parkinsons disease Drug Forecast by Regions
12.4.1 Global Parkinsons disease Drug Sales Forecast by Regions 2020-2030
12.4.2 Global Parkinsons disease Drug Revenue Forecast by Regions 2020-2030
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.
